Trichomegaly secondary to erlotinib

Canadian Journal of Ophthalmology

Volumn 44, Issue 6, 2009, Pages

  Desai, Rajen U ^a   Rachakonda, Leelanand P ^a   Saffra, Norman A ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB;

AGED; CANCER CHEMOTHERAPY; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYELASH; HAIR DISEASE; HAIR GROWTH; HUMAN; LETTER; LUNG ADENOCARCINOMA; MALE; MONOTHERAPY; TRICHOMEGALY;

EID: 72849128958     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i09-158     Document Type: Letter

References (4)

1. Zhang G, Basti S, Jampol LM. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature. Cornea 2007;26:858-860
2. Braiteh F, Kurzrock R, Johnson FM. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. J Clin Oncol 2008;26:3460-3462
3. Carser JE, Summers YJ. Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer. J Thorac Oncol 2006;1:1040-1041 (Pubitemid 47181376)
4. Hansen LA, Alexander N, Hogan ME, et al. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol 1997;150:1959-1975 (Pubitemid 27233070)